These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9092819)

  • 21. The hepatitis C virus NS3 proteinase: structure and function of a zinc-containing serine proteinase.
    De Francesco R; Pessi A; Steinkühler C
    Antivir Ther; 1998; 3(Suppl 3):99-109. PubMed ID: 10726060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
    Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
    J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Roles of the propeptide and metal ions in the folding and stability of the catalytic domain of stromelysin (matrix metalloproteinase 3).
    Wetmore DR; Hardman KD
    Biochemistry; 1996 May; 35(21):6549-58. PubMed ID: 8639603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of NH2-terminal pro-sequence in the production of active aqualysin I (a thermophilic serine protease) in Escherichia coli.
    Lee YC; Miyata Y; Terada I; Ohta T; Matsuzawa H
    Agric Biol Chem; 1991 Dec; 55(12):3027-32. PubMed ID: 1368764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-based design of inhibitors of NS3 serine protease of hepatitis C virus.
    Frecer V; Kabelác M; De Nardi P; Pricl S; Miertus S
    J Mol Graph Model; 2004 Jan; 22(3):209-20. PubMed ID: 14629979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the unfolding of alpha-lytic protease and the role of the pro region.
    Inuzuka Y; Lazaridis T
    Proteins; 2000 Oct; 41(1):21-32. PubMed ID: 10944390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pro-sequence and Ca2+-binding: implications for folding and maturation of Ntn-hydrolase penicillin amidase from E. coli.
    Ignatova Z; Wischnewski F; Notbohm H; Kasche V
    J Mol Biol; 2005 May; 348(4):999-1014. PubMed ID: 15843029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mapping of an internal protease cleavage site in the Ssy5p component of the amino acid sensor of Saccharomyces cerevisiae and functional characterization of the resulting pro- and protease domains by gain-of-function genetics.
    Poulsen P; Lo Leggio L; Kielland-Brandt MC
    Eukaryot Cell; 2006 Mar; 5(3):601-8. PubMed ID: 16524914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pro region N-terminal domain provides specific interactions required for catalysis of alpha-lytic protease folding.
    Cunningham EL; Mau T; Truhlar SM; Agard DA
    Biochemistry; 2002 Jul; 41(28):8860-7. PubMed ID: 12102628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteolytic processing of the human T-cell lymphotropic virus 1 reverse transcriptase: identification of the N-terminal cleavage site by mass spectrometry.
    Agbuya PG; Sherman NE; Moen LK
    Arch Biochem Biophys; 2001 Aug; 392(1):93-102. PubMed ID: 11469799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unfolded conformations of alpha-lytic protease are more stable than its native state.
    Sohl JL; Jaswal SS; Agard DA
    Nature; 1998 Oct; 395(6704):817-9. PubMed ID: 9796818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of ecotin dimerization in protease inhibition.
    Eggers CT; Wang SX; Fletterick RJ; Craik CS
    J Mol Biol; 2001 May; 308(5):975-91. PubMed ID: 11352586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correct folding of alpha-lytic protease is required for its extracellular secretion from Escherichia coli.
    Fujishige A; Smith KR; Silen JL; Agard DA
    J Cell Biol; 1992 Jul; 118(1):33-42. PubMed ID: 1618906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assembly of the type 1 procollagen molecule: selectivity of the interactions between the alpha 1(I)- and alpha 2(I)-carboxyl propeptides.
    Alvares K; Siddiqui F; Malone J; Veis A
    Biochemistry; 1999 Apr; 38(17):5401-11. PubMed ID: 10220327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The 0.83 A resolution crystal structure of alpha-lytic protease reveals the detailed structure of the active site and identifies a source of conformational strain.
    Fuhrmann CN; Kelch BA; Ota N; Agard DA
    J Mol Biol; 2004 May; 338(5):999-1013. PubMed ID: 15111063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Despite having a common P1 Leu, eglin C inhibits alpha-lytic proteinase a million-fold more strongly than does turkey ovomucoid third domain.
    Qasim MA; Van Etten RL; Yeh T; Saunders C; Ganz PJ; Qasim S; Wang L; Laskowski M
    Biochemistry; 2006 Sep; 45(38):11342-8. PubMed ID: 16981694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The folding mechanism of collagen-like model peptides explored through detailed molecular simulations.
    Stultz CM
    Protein Sci; 2006 Sep; 15(9):2166-77. PubMed ID: 16943446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetic and structural characterization of mutations of glycine 216 in alpha-lytic protease: a new target for engineering substrate specificity.
    Mace JE; Agard DA
    J Mol Biol; 1995 Dec; 254(4):720-36. PubMed ID: 7500345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A carboxy-terminal pro-sequence of aqualysin I prevents proper folding of the protease domain on its secretion by Saccharomyces cerevisiae.
    Kim DW; Lin SJ; Morita S; Terada I; Matsuzawa H
    Biochem Biophys Res Commun; 1997 Feb; 231(3):535-9. PubMed ID: 9070839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthetic peptides derived from the prosegments of proprotein convertase 1/3 and furin are potent inhibitors of both enzymes.
    Basak A; Lazure C
    Biochem J; 2003 Jul; 373(Pt 1):231-9. PubMed ID: 12662153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.